Dr. med. Dennis Kannenkeril

Department of Medicine 4 – Nephrology and Hypertension

Simultaneously measured inter-arm blood pressure difference is not associated with pulse wave velocity in a clinical dataset of at-risk hypertensive patients (2021) Nolde JM, Lugo-Gavidia LM, Kannenkeril D, Chan J, Robinson S, Jose A, Joyson A, et al. Journal article Dependency of flow-mediated vasodilatation from basal nitric oxide activity (2021) Kannenkeril D, Bosch A, Kolwelter J, Jung S, Striepe K, Ott C, Delles C, Schmieder R Journal article Renal and intraglomerular haemodynamics in chronic heart failure with preserved and reduced ejection fraction (2021) Jung S, Bosch A, Kolwelter J, Striepe K, Kannenkeril D, Schuster T, Ott C, et al. Journal article Retinal neurodegeneration in patients with end-stage renal disease assessed by spectral-domain optical coherence tomography (2020) Jung S, Bosch A, Ott C, Kannenkeril D, Dienemann T, Harazny JM, Michelson G, Schmieder R Journal article Combination of empagliflozin and linagliptin improves blood pressure and vascular function in type 2 diabetes (2020) Jung S, Bosch A, Kannenkeril D, Karg MV, Striepe K, Bramlage P, Ott C, et al. Journal article Microvascular changes at different stages of chronic kidney disease (2020) Kannenkeril D, Frost S, Nolde JM, Kiuchi MG, Carnagarin R, Lugo-Gavidia LM, Chan J, et al. Journal article Supine blood pressure—A clinically relevant determinant of vascular target organ damage in hypertensive patients (2020) Nolde JM, Kiuchi MG, Carnagarin R, Frost S, Kannenkeril D, Lugo-Gavidia LM, Chan J, et al. Journal article Validation of semi-automated flow-mediated dilation measurement in healthy volunteers (2020) Dobbie LJ, Mackin ST, Hogarth K, Lonergan F, Kannenkeril D, Brooksbank K, Delles C Journal article Combined therapy of empagliflozin and linagliptin is superior to metformin and insulin glargine in improving blood pressure and vascular function in type 2 diabetes (2019) Jung S, Bosch A, Kannenkeril D, Karg M, Striepe K, Bramlage P, Ott C, Schmieder R Conference contribution Tissue sodium concentration emerged as a determinant of hypertrophic vascular remodeling in type 2 diabetes (2019) Schmieder R, Jung S, Kannenkeril D, Harazny JM, Striepe K, Ott C, Linz P, et al. Conference contribution